June 3rd 2023
By Russ Conroy
A progression-free survival benefit was observed in patients with advanced ovarian cancer including those with homologous recombination deficient-positive status who were treated with frontline chemo plus Avastin and Imfinzi followed by maintenance therapy with an Avastin regimen.
June 3rd 2023
By Gina Mauro
Three-fourths of patients with relapsed/refractory B-cell acute lymphoblastic leukemia experienced complete responses — which tended to be durable — when treated with the CAR-T cell therapy, Obe-cel.
June 2nd 2023
By Gina Mauro
Results of the Canadian Cancer Trials Group CX.5/SHAPE trial could lead to surgical de-escalation among patients with cervical cancer.
June 2nd 2023
By Brielle Benyon
The third and final installment of the CURE® Open Mic Showcase features comedy, essay readings and videos from patients with cancer.
June 2nd 2023
By Debbie Legault
After my daughter was diagnosed with cancer, I began to share my experiences through writing, and through that I found camaraderie — and heartbreak.
June 2, 2023 5:00 PM
By Debbie Legault
June 1, 2023 9:00 PM
By Linda Cohen
June 1, 2023 5:00 PM
By Elizabeth McSpadden
May 31, 2023 11:00 PM
By Steve Rubin
May 12, 2023 7:00 PM
By Bryana Tanner
May 11, 2023 9:00 PM
By Robert Trebor
May 8, 2023 9:00 PM
By Denise Sirchie
May 4, 2023 1:00 PM
By Chester Freeman